Cite

HARVARD Citation

    Roncato, R. et al. (2017). Cost Evaluation of Irinotecan‐Related Toxicities Associated With the UGT1A1*28 Patient Genotype. Clinical pharmacology & therapeutics. 102 (1), pp. 123-130. [Online]. 
  
Back to record